Showing results (1551-1560 of 1,662) with videos related to
Sort By:
Pageof 167
Blood Advances|September 3, 2021
Identification of coagulation factor IX variants with enhanced activity through ancestral sequence reconstructionKristopher A Knight, Christopher W Coyle, Caelan E Radford, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 30, 2020
Comparison of Tissue-Based Molecular Markers in Younger versus Older Patients with Colorectal NeoplasiaPaul J Limburg, Douglas W Mahoney, David A Ahlquist, et al.Experimental Physiology|January 24, 2021
Low responders to endurance training exhibit impaired hypertrophy and divergent biological process responses in rat skeletal muscleDaniel W D West, Thomas M Doering, Jamie-Lee M Thompson, et al.BMC Cancer|October 17, 2012
Tissue tolerable plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivoLars Ivo Partecke, Katja Evert, Jan Haugk, et al.The Science of the Total Environment|September 11, 2021
Demonstration of an aggregated biomarker response approach to assess the impact of point and diffuse contaminant sources in feral fish in a small river case studyMarkus Schmitz, Björn Deutschmann, Nele Markert, et al.Nature Plants|June 3, 2016
V-ATPase activity in the TGN/EE is required for exocytosis and recycling in ArabidopsisYu Luo, Stefan Scholl, Anett Doering, et al.Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 18, 2004
Benefits of bilateral electrical stimulation with the nucleus cochlear implant in adults: 6-month postoperative resultsRoland Laszig, Antje Aschendorff, Matthias Stecker, et al.Cancers|December 23, 2023
Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer TherapiesMojun Zhu, William R Taylor, Douglas W Mahoney, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study GroupJalid Sehouli, Dirk Stengel, Philipp Harter, et al.Obstetrics and Gynecology|May 22, 2025
Intrapartum Doula Support and Cesarean Delivery Rates: A Systematic Review and Meta-analysisYasmin Dias, Nnenna E Achebe, Michelle M Doering, et al.Pageof 167